Literature DB >> 15829289

Single chain antibody fragments for the selective targeting of antigens to dendritic cells.

Caroline Demangel1, Jie Zhou, Andre B H Choo, Grant Shoebridge, Gary M Halliday, Warwick J Britton.   

Abstract

In order to target antigens (Ags) selectively to dendritic cells (DC), we derived single chain antibody fragments (scFvs) from NLDC-145 and N418, two monoclonal antibodies binding the mouse dendritic cell-restricted surface molecules DEC-205 and CD11c. Recombinant hexahistidine-tagged forms of the scFvs (scNLDC and scN418) were efficiently produced in a baculovirus expression system. Both scFvs bound DEC-205(+) Langerhans cells and CD11c(+) fetal skin-derived dendritic cells (FSDCs) comparably to their parental antibodies. Immunization of C57BL/6 mice with a DNA vaccine encoding a model protein antigen fused to scNLDC stimulated specific immune responses in both the humoral and cellular compartments, in contrast to DNA vaccines expressing scN418-targeted or untargeted antigen. Our results show that antigen targeting to DCs via a DEC-205 binding scFv leads to enhanced immunogenicity. Further, this work suggests that scFvs fused to protein antigens and delivered as DNA vaccines may provide a generic means for delivering vaccinal molecules to selected cell populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15829289     DOI: 10.1016/j.molimm.2004.09.034

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  30 in total

Review 1.  C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses.

Authors:  Lara M Kingeter; Xin Lin
Journal:  Cell Mol Immunol       Date:  2012-01-16       Impact factor: 11.530

Review 2.  Lepidopteran cells, an alternative for the production of recombinant antibodies?

Authors:  Martine Cérutti; Josée Golay
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

3.  The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells.

Authors:  Godwin Nchinda; Janelle Kuroiwa; Margarita Oks; Christine Trumpfheller; Chae Gyu Park; Yaoxing Huang; Drew Hannaman; Sarah J Schlesinger; Olga Mizenina; Michel C Nussenzweig; Klaus Uberla; Ralph M Steinman
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

4.  A versatile bifunctional dendritic cell targeting vaccine vector.

Authors:  Welson W Wang; Dipankar Das; Mavanur R Suresh
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

Review 5.  Current trends in tuberculosis vaccine.

Authors:  J S V Soundarya; Uma Devi Ranganathan; Srikanth P Tripathy
Journal:  Med J Armed Forces India       Date:  2019-01-18

6.  Targeting DNA vaccines to myeloid cells using a small peptide.

Authors:  Chunting Ye; Jang Gi Choi; Sojan Abraham; Premlata Shankar; N Manjunath
Journal:  Eur J Immunol       Date:  2014-11-02       Impact factor: 5.532

7.  Ligation of CD11c during vaccination promotes germinal centre induction and robust humoral responses without adjuvant.

Authors:  Ann L White; Alison L Tutt; Sonya James; Kevin A Wilkinson; Fernanda V V Castro; Sandra V Dixon; Jessica Hitchcock; Mahmood Khan; Aymen Al-Shamkhani; Adam F Cunningham; Martin J Glennie
Journal:  Immunology       Date:  2010-05-10       Impact factor: 7.397

8.  Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice.

Authors:  Jad Maamary; Frida Array; Qinshan Gao; Adolfo García-Sastre; Ralph M Steinman; Peter Palese; Godwin Nchinda
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

9.  Expression of a functional single-chain variable-fragment antibody against complement receptor 1 in Streptococcus gordonii.

Authors:  Jennifer B Knight; Scott A Halperin; Kenneth A West; Song F Lee
Journal:  Clin Vaccine Immunol       Date:  2008-04-02

10.  DC targeting DNA vaccines induce protective and therapeutic antitumor immunity in mice.

Authors:  Qun Wang; Wei Cao; Zhi-Gang Yang; Guang-Fa Zhao
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.